Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Ponatinib for chronic myeloid leukaemia in paediatric patients	Ponatinib (AP24534)	Chronic myeloid leukaemia (CML)	Haematological Cancer and Lymphomas	2024	View \| Download
Ponesimod for Relapsing-remitting Multiple Sclerosis	Ponesimod (ACT-128800; RG-3477)	Multiple sclerosis (MS)	Neurology	2017	View \| Download
Potassium citrate and potassium bicarbonate for distal renal tubular acidosis – first line	Sibnayal (ADV 7103) (fixed dose combination: Potassium bicarbonate; Potassium citrate)	Distal renal tubular acidosis	Endocrine Nutritional and Metabolic Disorders , Nephrology	2020	View \| Download
Potassium citrate-potassium bicarbonate prolonged release granules for treating cystinuria	Potassium citrate-potassium bicarbonate	Cystinuria	Endocrine Nutritional and Metabolic Disorders , Genetic Disorders , Nephrology	2022	View \| Download
Pralsetinib for RET-fusion positive metastatic non-small-cell lung cancer	Pralsetinib (BLU-667; Gavreto)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2020	View \| Download
Pralsetinib for treating thyroid cancer	Pralsetinib (BLU-667; Gavreto)	Thyroid cancer	Oncology	2021	View \| Download
Pridopidine for treating Huntington’s disease in adults	Pridopidine	Huntington's disease	Genetic Disorders , Neurology	2024	View \| Download
PV-10 for Locally Advanced Cutaneous Melanoma	PV-10 (rose bengal sodium)	Melanoma	Skin Cancer	2018	View \| Download
PXT3003 for Charcot-Marie-Tooth Disease Type 1A	PXT-3003 (fixed dose combination: baclofen; Naltrexone hydrochloride; sorbitol)	Charcot-Marie-Tooth disease	Genetic Disorders , Neurology	2018	View \| Download
PXT3003 for treating Charcot-Marie-Tooth disease type 1A	PXT-3003 (fixed dose combination: baclofen; Naltrexone hydrochloride; sorbitol)	Charcot-Marie-Tooth disease	Genetic Disorders , Neurology	2023	View \| Download